BMI requirements exist because medications have both benefits and risks, and the thresholds help identify patients for whom benefits clearly outweigh risks
In patients with obesity (mean age 51.3 years, 65.6% women), semaglutide compared with non-GLP-1RA anti-obesity medications was associated with lower risk for incident CUD in patients with no prior history CUD (HR: 0.56, 95% CI: 0.420.75), and recurrent CUD diagnosis in patients with a prior history CUD (HR: 0.62, 95% CI: 0.460.84)
Some researchers perform well on lower carbohydrate approaches that maximize the metabolic benefits of fat oxidation
It was unfamiliar terrain for us parent-types
In the last two decades, a good number of studies have been published that showcase the impact of carnitine supplementation on female fertility
One such investigation is underway, but results aren't expected for more than a year